1. Home
  2. EARN vs XBIT Comparison

EARN vs XBIT Comparison

Compare EARN & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • XBIT
  • Stock Information
  • Founded
  • EARN 2012
  • XBIT 2005
  • Country
  • EARN United States
  • XBIT United States
  • Employees
  • EARN N/A
  • XBIT N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • XBIT Pharmaceuticals and Biotechnology
  • Sector
  • EARN Real Estate
  • XBIT Health Care
  • Exchange
  • EARN Nasdaq
  • XBIT Nasdaq
  • Market Cap
  • EARN 187.6M
  • XBIT 194.5M
  • IPO Year
  • EARN 2013
  • XBIT 2015
  • Fundamental
  • Price
  • EARN $6.60
  • XBIT $3.25
  • Analyst Decision
  • EARN Hold
  • XBIT
  • Analyst Count
  • EARN 1
  • XBIT 0
  • Target Price
  • EARN N/A
  • XBIT N/A
  • AVG Volume (30 Days)
  • EARN 639.2K
  • XBIT 52.0K
  • Earning Date
  • EARN 03-05-2025
  • XBIT 03-14-2025
  • Dividend Yield
  • EARN 14.53%
  • XBIT N/A
  • EPS Growth
  • EARN 277.67
  • XBIT N/A
  • EPS
  • EARN 1.02
  • XBIT N/A
  • Revenue
  • EARN N/A
  • XBIT N/A
  • Revenue This Year
  • EARN N/A
  • XBIT N/A
  • Revenue Next Year
  • EARN $89.08
  • XBIT N/A
  • P/E Ratio
  • EARN $6.46
  • XBIT N/A
  • Revenue Growth
  • EARN N/A
  • XBIT N/A
  • 52 Week Low
  • EARN $5.54
  • XBIT $3.25
  • 52 Week High
  • EARN $7.26
  • XBIT $9.96
  • Technical
  • Relative Strength Index (RSI)
  • EARN 48.80
  • XBIT 26.88
  • Support Level
  • EARN $6.53
  • XBIT $3.40
  • Resistance Level
  • EARN $6.82
  • XBIT $3.69
  • Average True Range (ATR)
  • EARN 0.13
  • XBIT 0.20
  • MACD
  • EARN 0.00
  • XBIT 0.05
  • Stochastic Oscillator
  • EARN 40.26
  • XBIT 3.85

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: